SeriACL™ Device (Gen IB) Trial for Anterior Cruciate Ligament (ACL) Repair

Clinical trial NCT00775892 · COMPLETED

Trial details

NCT number: NCT00775892
Sponsor: Serica Technologies, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anterior Cruciate Ligament Reconstruction

Start date: 2008-09-01
Primary completion: 2010-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.